Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afuresertib plus Paclitaxel in Platinum-Resistant Ovarian Cancer
NCT04374630Phase 2Completed
- Sponsor
- Laekna
- Start
- Jul 2020
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of afuresertib in ovarian cancer, sponsored by Laekna. Started Jul 2020; status: completed.
02
Drugs
afuresertib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT04374630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04374630.